Takeda Pharmaceutical shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Takeda Pharmaceutical (TAK) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Takeda Pharmaceutical
Tip: Access up to 7 years of quarterly data
All positions including Takeda Pharmaceutical held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Takeda Pharmaceutical by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $1.0M | 56k | 18.52 |
| 2025-12-31 | $166k | 11k | 15.59 |
| 2019-12-31 | $439k | 22k | 19.73 |
| 2019-09-30 | $11M | 632k | 17.20 |
| 2019-06-30 | $10M | 584k | 17.70 |
| 2019-03-31 | $13M | 639k | 20.37 |
| 2018-12-31 | $6.9M | 413k | 16.82 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas